Ignite Creation Date:
2025-12-24 @ 2:03 PM
Ignite Modification Date:
2026-01-03 @ 9:30 AM
Study NCT ID:
NCT00518895
Status:
COMPLETED
Last Update Posted:
2011-11-07
First Post:
2007-08-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
Sponsor:
Genta Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AGENDA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None